Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.

The promoter of the human dihydrofolate reductase (DHFR) gene contains two consensus binding sites for the DNA binding protein Sp1. DNAse protection and gel mobility shift assays demonstrate binding of recombinant Sp1 to both decanucleotide Sp1 binding sequences which are located 49 and 14 base pair...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Blume, S W, Snyder, R C, Ray, R, Thomas, S, Koller, C A, Miller, D M
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1991
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295684/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1834700/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115474
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!